Accelerated Technology Laboratories, Inc Company Profile

07:52 EDT 18th March 2018 | BioPortfolio

Accelerated Technology Laboratories, Inc. is a privately held company, formed in 1994 in the Silicon Valley in response to the need for an easy to use and affordable LIMS. There were over two dozen LIMS solutions on the market at the time, but none of these systems were based on Windows® or could be easily used. ATL pioneered Windows-based LIMS. Microsoft Access® was selected as the database engine because it offered advanced functions such as referential integrity, rushmore technology for fast queries and excellent integration with other Windows™ applications such as Excel, Word, PowerPoint and WordPerfect. In addition, Microsoft Access® utilizes Visual Basic as the programming language due to its robust and sophisticated nature. ATL pioneered Microsoft Access® based LIMS and offered the first commercially available system.
ATL, Inc. experienced rapid success and quickly introduced the enterprise edition, Sample Master® Pro, based on Microsoft SQL Server or ORACLE. This was followed by the introduction of iLIMS, a web-based LIMS for clients with multiple sites, ScreenIT™ Pro for manufacturing environments, and NeoMate™ for newborn genetic screening and metabolic disease screening. Other products include Sample Master® LIMS Explorer to web-enable Sample Master® and a host of additional products including CLP/EDD packages for organics, inorganics and wet chemistry, a fieldworker for remote data collection, a biomouse for biometric ID and electronic signatures and integration with handheld devices for remote field collection. Additionally, ATL has a library of over 250 instrument files that have been previously integrated with its LIMS products. ATL has provided LIMS solutions for a number of Fortune 500 companies and many other laboratories that are ISO, CAP/CLIA, ELAP or NELAC certified.


496 Holly Grove School Road
West End
North Carolina
United States of America


Phone: 910.673.8165
Fax: 910.673.8166

News Articles [470 Associated News Articles listed on BioPortfolio]

Accelerated access pathway introduced by UK

The UK Department of Health published a report giving details on its accelerated access review program and accelerated access -More- 

FDA grants accelerated approval to AZ's blood cancer drug

British-based AstraZeneca's Calquence, or acalabrutinib, has been granted accelerated approval by the FDA for use as a treatm -More- 

Accelerated access to new drugs and technologies

In a new report,1 the UK government has endorsed the recommendations of last year’s accelerated access review2 and announced its plans to introduce a faster route to market for “strategically... ...

EMA Grants Alnylam Accelerated Assessment Of Patisiran

WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has granted an accelerated a...

New technology for accelerated wound healing discovered

Researchers have found a new way of accelerating wound healing. The technology and the mode of action involves using lactic acid bacteria as vectors to produce and deliver a human chemokine on site in...

U.K. pharma view on gov’t response to the Accelerated Access Review

The Government’s response to the Accelerated Access Review (AAR) was published in a bid to dramatically speed up the time it takes for patients to benefit from ground-breaking treatments for con...

BRIEF—Calquence wins accelerated approval for mantle cell lymphoma

The UK’s AstraZeneca has been handed accelerated approval in the USA for its Calquence for adults with…

Rare Diseases: Growing Understanding Will Unlock Accelerated Approval, FDA Says

US FDA officials say they need knowledge of the disease to have the confidence to use accelerated approval.   

PubMed Articles [1030 Associated PubMed Articles listed on BioPortfolio]

Review of Clinical Next-Generation Sequencing.

- Next-generation sequencing (NGS) is a technology being used by many laboratories to test for inherited disorders and tumor mutations. This technology is new for many practicing pathologists, who may...

Interlaboratory reproducibility of droplet digital polymerase chain reaction using a new DNA reference material format.

Use of droplet digital PCR technology (ddPCR) is expanding rapidly in the diversity of applications and number of users around the world. Access to relatively simple and affordable commercial ddPCR te...

Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.

Cellular immunological assays are important tools for the monitoring of responses to T-cell-inducing vaccine candidates. As these bioassays are often technically complex and require considerable exper...

Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology.

Many European laboratories offer molecular genetic analysis of the CFTR gene using a wide range of methods to identify mutations causative of cystic fibrosis (CF) and CFTR-related disorders (CFTR-RDs)...

Repeatability and variability of total T4 measurements at three German veterinary laboratories.

To evaluate the reproducibility of serum testing for total thyroxine (T4) in three German laboratories.

Clinical Trials [1754 Associated Clinical Trials listed on BioPortfolio]

Accelerated Radiotherapy and Concomitant Chemo-Radiotherapy in HNSCC

This is a multicentric randomized phase III trial comparing conventional radiotherapy with concomitant chemotherapy versus accelerated radiotherapy with concomitant chemotherapy versus ver...

Accelerated Rehabilitation After Arthroscopic Bankart Repair Surgery

The aim of this study was to prospectively evaluate the efficacy of an accelerated rehabilitation regime for patients undergoing early arthroscopic stabilization for first-time anterior di...

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

This is a monocentric prospective study of radiotherapy using accelerated hypofractionation with Tomotherapy in Malignant Pleural Mesothelioma (MPM) patients after pleurectomy / decorticat...

MR Urography vs CT Urography

Tumors of the UUT are rare and usually presenting as micro- or macrohematuria either symptomatic or asymptomatic. Rapid advances in CT technology accelerated the research into the applicat...

Modulated Accelerated RAdiotherapy in Early Breast Cancer

This trial was a retrospective study on postoperative accelerated hypofractionated IMRT (MARA-1) in patients with early stage breast carcinoma, to compare late toxicity after this treatmen...

Companies [1600 Associated Companies listed on BioPortfolio]

Accelerated Cure Project

Accelerated Cure Project for Multiple Sclerosis,, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its cause...

Accelerated Technology Laboratories, Inc

Accelerated Technology Laboratories, Inc. is a privately held company, formed in 1994 in the Silicon Valley in response to the need for an easy to use and affordable LIMS. There were over two dozen L...

Milestone Inc.

Milestone was founded in 1989, to provide chemists around the world with advanced microwave platforms on which to accelerate all their sample preparation requirements. Today, with a global installed b...

The Foundation for Accelerated Vascular Research

The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...


Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Accelerated Technology Laboratories, Inc" on BioPortfolio

We have published hundreds of Accelerated Technology Laboratories, Inc news stories on BioPortfolio along with dozens of Accelerated Technology Laboratories, Inc Clinical Trials and PubMed Articles about Accelerated Technology Laboratories, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accelerated Technology Laboratories, Inc Companies in our database. You can also find out about relevant Accelerated Technology Laboratories, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Corporate Database Quicklinks

Searches Linking to this Company Record